BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Blinatumomab: Phase II started

Micromet began a single-arm, international Phase II trial to evaluate blinatumomab for 28 days followed by 2 weeks off therapy for up to 5 cycles in about 65 adult patients. Micromet said the trial is the first of 2 planned...

Read the full 176 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >